



EFFECT OF TOLL-LIKE RECEPTOR INHIBITOR IMIQUIMOD ON IL1R1 INTERACTION WITH IL-
1RA AND ITS SNP VARIANT-AN IN SILICO APPROACH 
Original Article 
 
ANAND THIYAGARAJ, JITHIN S. SUNNY, WAHEETA HOPPER* 
Department of Bioinformatics, School of Bioengineering, Faculty of Engineering Technology, SRM University, Kattankulathur 603203, 
Tamil Nadu, India 
Email: hod.bioinfo@ktr.srmuniv.ac.in  
 Received: 21 Jan 2016 Revised and Accepted: 15 Mar 2016 
ABSTRACT 
Objective: Interleukin 1 receptor antagonist (IL1Ra) acts as an antagonist to Interleukin 1 beta (IL1β) signalling in maintaining homeostasis. A loss 
of function due to Single Nucleotide Polymorphism (SNP) occurrence in IL1Ra can lead to dysregulated state as seen in autoimmune disease 
pathogenesis. The current study aims at achieving conformational stability in the IL1R1-IL1Ra_SNP complex by introducing a ligand into the region 
apart from the active site of Interleukin 1 receptor type1 (IL1R1).  
Methods: Protein-protein docking was performed using ClusPro, for IL1R1 with IL1β, IL1Ra and IL1Ra_SNP variant to study the difference in the 
interaction between the complexes. A known inhibitor, Imiquimod was docked using Glide, to the Il1R1-IL1Ra_SNP complex using flexible docking 
and the change in surface energy was calculated.  
Results: Binding Interactions show that IL1Ra binds more avidly to IL1R1 than IL1β. Conformational instability was seen in the IL1R1-IL1Ra_SNP 
complex. The difference in the amino acid interactions between the IL1R1 with IL1Ra and IL1Ra_SNP variant further illustrated the change in 
binding residues and hydrogen bond formation. Upon docking of an appropriate ligand to the IL1R1-IL1Ra_SNP complex, the conformational 
stability of the IL1R1-IL1Ra_SNP complex enhanced considerably suggesting a possible mechanism for treating SNP-induced conformational 
instability. 
Conclusion: Toll-like receptors like IL1R1 have many binding pockets apart from its active site. No strategies have yet been reported in targeting 
them for correcting conformational instability induced by SNP. Through our study, it was observed that the conformational instability of IL1R1-
IL1Ra_SNP complex decreased upon introducing an appropriate small molecule. 
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INTRODUCTION 
Inflammation is the body's protective response to injury and 
infection. It is a complex process involving many cell types, as well 
as different components of blood interacting with each other to 
maintain homeostasis. Autoimmunity is a condition which leads to 
failure of our immune system to differentiate our cells with foreign 
agents. Among many cell types, T-helper cell (Th cell) differentiation 
has been chiefly associated with Systemic Autoimmune disease like 
Rheumatoid Arthritis (RA)[1]. Pro-inflammatory cytokines 
signalling plays a crucial role in autoimmune disease pathogenesis 
as they regulate T-helper cell differentiation. 
More than any other pro-inflammatory cytokine family, the 
interleukin 1 (IL1) family is closely linked to the innate immune 
response. Its role along with IL1Ra in Th17 differentiation is critical 
in autoimmune disease pathogenesis. IL1Ra deficient mice develop 
autoimmune arthritis in which IL17A plays a crucial role [2]. The 
cytoplasmic domain of the IL1R1 is highly homologous to the 
cytoplasmic domains of all Toll-like receptors (TLR) [3]. IL1β is the 
most studied member of the IL1 family because of its role in 
mediating autoimmune diseases. Although the TLR and IL1 families 
evolved to assist in host defence against infection, unlike the TLR 
family, the IL1 family also includes members that suppress 
inflammation, both specifically within the IL1 family but also non-
specifically for TLR ligands and the innate immune response [4]. 
IL1 type cytokines are major mediators of innate immune reactions, 
Interleukin 1 alpha (IL1α) and IL1β promote an inflammatory 
process which is regulated by IL1Ra antagonist activity [5]. IL1α and 
IL1β rapidly increase mRNA expression of hundreds of genes in 
different cell types [6]. The potent pro-inflammatory activities of 
IL1β and IL1α are restricted at three major levels: (i) synthesis and 
release of IL1β and IL1α (ii) membrane receptors IL1R1 and IL1R2 
and (iii) intracellular signal transduction. In response to IL1β 
binding to IL1R1, the cell undergoes a complex sequence of 
combinatorial phosphorylation and ubiquitination of second 
messengers resulting in activation of Nuclear Factor kappa B 
signalling, Janus Kinase, p38 and Mitogen-Activated Protein Kinase 
(MAPK) pathway proteins, which cooperatively induce the 
expression of canonical IL1 target genes (such as IL6, IL8, Monocyte 
Chemoattractant Protein-1, Cyclooxygenase-2, IL1α, IL1β, Map 
Kinase Phosphatase-1) by transcriptional and posttranscriptional 
mechanisms [7]. Dysregulated, prolonged synthesis and release of 
IL-1 cytokines in chronic inflammatory situations contribute to 
Systemic autoimmune diseases like rheumatoid arthritis [8]. IL1Ra 
as an antagonist to IL1β, binds to IL1R1 and inhibits IL1β mediated 
cellular proliferation [9]. The IL1R1 shares same binding site for 
IL1β and IL1Ra [10]. IL1Ra is an important natural anti-
inflammatory protein, and any loss of its function could lead to an 
autoimmune condition like rheumatoid arthritis [11]. Many SNP’s 
have been associated to IL1Ra, among these, the non-synonymous 
SNPs could potentially induce conformational instability in IL1R1-
IL1Ra complex, thereby leading to dysregulation of the Th cell 
signalling mechanism and leading to loss of homeostasis which 
contributes to autoimmune disease pathogenesis [12]. The 
comparative conformational analysis of the underlying mechanisms 
involved in IL1R1 complex formation with IL1β, IL1Ra and the effect 
of non-synonymous SNP variant (IL1Ra_SNP) can provide insights 
into conformational stability [13]. A ligand-induced conformational 
stability for the IL1R1-IL1Ra_SNP complex has been explored. 
MATERIALS AND METHODS 
PDB IDs: 3O4O, 31B1 and 1ILR for IL1R1, IL1β and IL1Ra 
respectively were retrieved from Protein Data Bank (PDB) with a 
resolution ranging from 2Å to 3Å [14]. Homology modelling was 
performed using Easy Modeller for IL1Ra_SNP variant and IL1R1 
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using IL1Ra and IL1R1 PDB structures respectively as the template 
[15]. Protein-protein docking for IL1R1 with IL1β, IL1Ra and 
IL1Ra_SNP variant was performed using ClusPro, an online server to 
get the respective complex structure and their binding energies [16]. 
Chrion, a rapid protein energy minimization server was used to 
minimize the docked complexes IL1R1-IL1β, IL1R1-IL1Ra, and 
IL1R1-IL1Ra_SNP [17]. The docking and minimization structures 
were visualised using Pymol and the structure was coloured based 
on chains. The SNP’s associated with IL1Ra were identified from 
dbSNP [18]. Among 2525 SNPs, a non-synonymous SNP, 
rs45507693 was predicted to induce conformational instability 
resulting from Alanine to Threonine substitution in IL1Ra.  
LIGPLOT+,a program that generates a schematic representation of 
protein-ligand interaction was used to find the interaction surface 
to elaborate the difference in the binding of IL1R1 with IL1β and 
IL1Ra [19]. SCFbio, an online supercomputing facility was used to 
find out all the possible binding pockets in the receptor apart from 
the active site, which could act as potential regions for ligand 
binding [20]. Glide 6.7 (Schrödinger Inc.) was used to perform 
docking studies of IL1R1-IL1Ra_SNP complex with Imiquimod, a 
known inhibitor of Toll-like Receptor [21]. Surface area changes 
for the complexes were studied using Inter Pro Surf, which is used 
to find the total surface area of protein in its monomeric and 
complex forms [22]. 
RESULTS  
The 3D models of IL1R1 and IL1Ra_SNP variant was predicted by 
Homology modelling, and the structural validation was performed 
using Ramachandran plot. The maximum amino acids distribution 
was found in the allowed region. Root Mean Square deviation 
(RMSD) was predicted between the IL1Ra and IL1Ra_SNP variant to 
be 0.890. The RMSD clearly indicates the conformational change 
induced by the SNP. 
Protein-protein docking studies performed for IL1R1 with IL1β and 
IL1Ra suggested that IL1Ra binds more avidly to IL1R1 than IL1β. 
Binding free energy scores in table 1 shows that IL1Ra antagonist 
binding with IL1R1 plays a crucial role in controlling inflammatory 
mechanism and any conformational disturbance in IL1R1-IL1Ra 
complex can lead to dysregulation in homeostasis as found in 
autoimmune diseases. 
Comparison of IL1R1-IL1Ra complex with IL1R1-IL1Ra_SNP 
complex 
IL1R1 was docked with IL1Ra_SNP variant. Upon comparing binding 
free energies of three complexes as shown in table 1, it was 
observed that the binding free energies of the IL1R1-IL1Ra_SNP 
complex decreased considerably than the IL1R1-IL1Ra complex. The 
structure of the docked complexes IL1R1-IL1Ra and IL1R1-
IL1Ra_SNP clearly shows the conformational change between the 
two complexes as shown in fig. 1. 
 
Table 1: Comparison of binding free energy for IL1R1-IL1β, 
IL1R1-IL1Ra, and IL1R1-IL1Ra_SNP complexes 







Fig. 1: (a) Interaction of IL1R1 with IL1Ra (b) Interaction of IL1R1 with IL1Ra_SNP variant. IL1Ra is represented in blue colour wireframe 
and its receptor IL1R1 in green colour ribbon format 
 
To elaborate the difference in binding between, the interacting 
surface of the IL1R1-IL1Ra complex and the IL1R1-IL1Ra_SNP 
complex was studied. The amino acids participating in the Hydrogen 
bond interactions between ligand and receptor for both complexes 
are shown in table 2. The change in bond formation was the 
contributing factor to the conformational change. Among the 
interactions, IL1R1-IL1Ra complex has more hydrophobic amino 
acids participating in stabilising the conformation which was 
observed to be reduced in IL1R1-IL1Ra_SNP complex. Further, the 
set of amino acids involved in the both complexes are different. 
 
Table 2: Residues forming Hydrogen Bonds in IL1R1-IL1Ra and IL1R1-IL1Ra_SNP complexes 
a. IL1R1 with IL-Ra 
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b. IL1R1 with IL1Ra-SNP variant 












Increasing conformational stability in IL1R1-IL1Ra_SNP using a 
known inhibitor, Imiquimod 
To induce conformational stability in the IL1R1-IL1Ra_SNP complex, 
a protein-ligand interaction was performed. IL1R1 was analysed 
using SCFBio for finding binding pockets other than IL1Ra binding 
site. Out of 46 cavities generated in IL1R1, only 21 sites not used by 
IL1Ra binding were considered for docking studies. The residues 
listed in table 2 were also eliminated prior to docking. The final 
selected region for docking ranged from Proline26 to Arginine 89. A 
known inhibitor, Imiquimod was docked with the IL1R1-IL1Ra_SNP 
complex using Glide. Imiquimod is a common drug for psoriasis and 
targets Toll-like receptors. It has 2 H-bond donors and 4 H-bond 
acceptors. It has an xlogP value of 2.66 and has a net charge of 0 
[23]. To study the surface area changes, the total surface area of 
protein in its monomeric and complex form were predicted. The 
docked complex consisting of IL1R1-IL1Ra_SNP with Imiquimod is 




Fig. 2: (a) Docking image of Imiquimod bound to IL1R1-IL1Ra_SNP complex. (b) Non-bonded interactions between IL1R1 and Imiquimod 
 
The presence of the ligand changed the surface area which is 
evident that it can alter the conformational effect induced by 
interaction with IL1Ra_SNP variant. The changes in surface area of 
IL1R1-IL1β, IL1R1-IL1Ra, IL1R1-IL1Ra_SNP complexes, and 
IL1R1-IL1Ra_SNP with Imiquimod complex are shown in table 3. A 
comparison was drawn between total surface energy and polar 
area energy for generated complexes as shown in table 3, the total 
surface energy for Il1R1-IL1Ra and IL1R1-IL1Ra_SNP complex was 
21387.10 and 17694.89 respectively. On a known ligand 
imiquimod, the total surface energy, and polar area energy 
improved for the IL1R1-IL1Ra_SNP complex increased to 
17870.66. The change in surface energy suggests a definite shift in 
conformational stability of the IL1R1-IL1Ra_SNP-Imiquimod 
complex. 
 
Table 3: Total surface energy and polar energy difference between IL1R1-IL1β, IL1R1-IL1Ra, IL1R1-IL1Ra_SNP, and IL1R1-
IL1Ra_SNP+imiquimod 
Protein-protein complex Polar area/energy Total area/energy Number of surface atom Number of buried atom 
IL1R1+IL1β  7170.28 22116.48 2114 1633 
IL1R1+IL1Ra  7095.70 21387.10 2011 1730 
IL1R1+IL1Ra_SNP  5844.79 17694.89 1494 1053 
IL1R1+IL1Ra_SNP+imiquimod 6203.02 17870.66 1477 1070 
 
DISCUSSION 
IL1β downstream signalling plays a significant role in the IL-23/IL-
17 proliferation. Studies show that the effect of gene polymorphism 
in the IL1 system has an effect on the inflammatory pathway, 
suggesting that any change in the IL1 pathway could contribute to 
autoimmune disease pathogenesis [24]. IL1R1 binds more avidly to 
IL1Ra than IL1β [25]. Protein-protein interaction studied between 
IL1R1-IL1β and IL1R1-IL1Ra predicted minimal free energy 
associated with the complexes. Minimum free energy implies that 
lesser the energy maximum the stability of the complex [26]. 
Docking studies performed suggest that the binding free energy of 
IL1Ra is minimum compared to IL1β, and establishes a more stable 
complex than IL1β, this factor could be critical in establishing the 
antagonistic role of IL1Ra and in maintaining the homeostasis. When 
comparing the binding free energy of IL1Ra_SNP to IL1Ra with 
IL1R1, it was observed that the binding affinity of IL1Ra_SNP 
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reduced considerably than IL1Ra but remained higher than that of 
IL1β. This provides insight that IL1Ra_SNP has more binding affinity 
than IL1β but fails to establish the same conformational stability as 
IL1Ra. This could be a possible factor in contributing to the 
sustained signalling proliferation as seen in autoimmune disease 
pathogenesis. 
The conformational stability of IL1R1-IL1Ra complex is contributed 
by interacting residues occurring on the active site. Analysis of the 
surface interaction of the IL1R1-IL1Ra complex suggested that 
presence of more hydrophobic residues was seen than polar 
residues. This is suggestive of the fact that the presence of 
hydrophobic residues contributes to a more tight complex formation 
by expelling the water out of the active site. The presence of 
hydrophobic amino acids participating in interaction could also be 
the reason for the minimal free energy of the complex. Comparing 
the surface interaction residues of the IL1R1-IL1Ra complex with 
IL1R1-IL1Ra_SNP complex, it was observed that an increase in polar 
residues contributed to surface interaction. The presence of polar 
residues increases the van der Waals force, which could be the 
contributing factor to increase in free energy and thereby to 
decrease the stability. The SNP occurrence interferes with the 
overall conformation of the complex and could influence the 
regulation on the cytosolic part of the receptor and thereby 
influencing its function. 
The overall interacting surface area is critical in maintaining the 
activity of the IL1R1-IL1Ra complex. In the IL1R1-IL1Ra_SNP 
complex, a strategy for re-establishing the total surface area was 
performed, by targeting the allosteric site of IL1R1, using a known 
inhibitor imiquimod. The total surface energy improved 
considerably for the IL1R1-IL1Ra_SNP+Imiquimod complex. 
Analysis of interacting surface revealed that upon binding the 
inhibitor, the number of buried atoms participating in the 
interacting region increased compared to the IL1R1-IL1Ra_SNP 
complex without the inhibitor. Also, the change in the surface area 
shifted towards the IL1R1-IL1Ra complex. This approach suggests 
that targeting allosteric sites in SNP variants could establish 
conformational stability in receptor-ligand complex and thereby 
regulating the downstream signalling process. Although allosteric 
sites have been previously targeted for inhibiting receptor-mediated 
signal [27], no approach to use small molecule has been reported in 
inducing conformational stability in SNP variants. 
CONCLUSION 
SNP-induced conformational instability can cause dysregulation of 
the IL1 system. A strategy for establishing conformational stability 
by targeting allosteric sites in IL1R1-IL1Ra_SNP complex helped in 
regaining the conformational stability of the complex. Exploring 
other binding pockets of TLR with similar computationally driven 
strategy can also provide conformational stability and thereby 
increasing the binding affinity of the SNP variants. 
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